These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28951401)

  • 21. Stroke prevention for patients with atrial fibrillation: improving but not perfect yet.
    Sandhu RK; McAlister FA
    Heart; 2013 Aug; 99(16):1141-2. PubMed ID: 23520398
    [No Abstract]   [Full Text] [Related]  

  • 22. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
    Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
    Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.
    Brandes A; Overgaard M; Plauborg L; Dehlendorff C; Lyck F; Peulicke J; Poulsen SV; Husted S
    Clin Cardiol; 2013 Jul; 36(7):427-32. PubMed ID: 23670894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
    Wertheimer G; Bereznicki LR
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.
    Osseby GV; Benatru I; Sochurkova D; Urbinelli R; Megherbi SE; Couvreur G; Moreau T; Wolf J; Giroud M
    Prev Med; 2004 Feb; 38(2):121-8. PubMed ID: 14715203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.
    Jedsadayanmata A
    J Med Assoc Thai; 2013 Jan; 96(1):91-8. PubMed ID: 23720984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
    Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C;
    Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
    Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
    Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data.
    Preuss R; Chenot JF; Angelow A
    Ger Med Sci; 2016; 14():Doc13. PubMed ID: 27980520
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke: Atrial fibrillation, stroke prevention therapy and aging.
    Spence JD
    Nat Rev Cardiol; 2009 Jul; 6(7):448-50. PubMed ID: 19554003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey.
    Holt TA; Hunter TD; Gunnarsson C; Khan N; Cload P; Lip GY
    Br J Gen Pract; 2012 Oct; 62(603):e710-7. PubMed ID: 23265231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.
    Robson J; Dostal I; Mathur R; Sohanpal R; Hull S; Antoniou S; Maccallum P; Schilling R; Ayerbe L; Boomla K
    Br J Gen Pract; 2014 May; 64(622):e275-81. PubMed ID: 24771841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Use of Oral Anticoagulants in Patients with Atrial Fibrillation in the Emergency Department.
    Hua H; Sur N; Choi J; Polineni S; Lee L; Chaturvedi S
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104599. PubMed ID: 32001107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.